Critical Path Institute and Roche's Ventana Medical Systems will lead the effort to develop the lab, which aims to advance personalized medicine in the Grand Canyon State by developing standards and best practices for accurately identifying biomarkers of patients.
CSHL secured $23.4 million of stimulus funding in 19 awards. The largest award, at more than $4.7 million over two years from the National Cancer Institute, funded the creation of a Molecular Target Discovery and Development Center.
In interviews this past week, officials at three research institutes said that the end of ARRA funding is not expected to hinder their research efforts, while two other institutes receiving funding from the stimulus measure held off on commenting.
Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.